Operating Cash Flow
Thermo Fisher Scientific Operating Cash Flow decreased by 65.5% to $1.19B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 64.9%, from $723.00M to $1.19B. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a -4.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Consistently high operating cash flow indicates a healthy, self-sustaining business capable of funding its own growth and returning capital to shareholders.
Detailed definition
Net cash from operating activities measures the total amount of cash generated by a company's core business operations....
Peer comparison
Investors often compare this to capital expenditures to calculate Free Cash Flow, a primary valuation metric for mature tech giants.
net_cash_from_operatingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.23B | $2.65B | $2.46B | $2.20B | $1.53B | $1.94B | $3.49B | $729.00M | $1.54B | $2.41B | $3.72B | $1.25B | $1.96B | $2.17B | $3.29B | $723.00M | $1.40B | $2.24B | $3.46B | $1.19B |
| QoQ Change | — | +19.0% | -7.3% | -10.4% | -30.6% | +26.8% | +80.0% | -79.1% | +111.2% | +56.8% | +54.2% | -66.4% | +56.7% | +10.5% | +51.9% | -78.0% | +93.5% | +60.0% | +54.4% | -65.5% |
| YoY Change | — | — | — | — | -31.4% | -26.9% | +41.9% | -66.9% | +0.8% | +24.6% | +6.8% | +71.6% | +27.3% | -10.3% | -11.6% | -42.2% | -28.6% | +3.4% | +5.1% | +64.9% |
Operating Cash Flow at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's operating cash flow?
- Thermo Fisher Scientific (TMO) reported operating cash flow of $1.19B in Q1 2026.
- How has Thermo Fisher Scientific's operating cash flow changed year-over-year?
- Thermo Fisher Scientific's operating cash flow increased by 64.9% year-over-year, from $723.00M to $1.19B.
- What is the long-term trend for Thermo Fisher Scientific's operating cash flow?
- Over 4 years (2021 to 2025), Thermo Fisher Scientific's operating cash flow has grown at a -4.3% compound annual growth rate (CAGR), from $9.31B to $7.82B.
- What does operating cash flow mean?
- The actual amount of cash a company brings in from its day-to-day business activities.